Abstract is: Assisted reproductive technology (ART) includes medical procedures used primarily to address infertility. This subject involves procedures such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), cryopreservation of gametes or embryos, and/or the use of fertility medication. When used to address infertility, ART may also be referred to as fertility treatment. ART mainly belongs to the field of reproductive endocrinology and infertility. Some forms of ART may be used with regard to fertile couples for genetic purpose (see preimplantation genetic diagnosis). ART may also be used in surrogacy arrangements, although not all surrogacy arrangements involve ART.The existence of sterility will not always require ART to be the first option to consider, as there are occasions when its cause is a mild disorder that can be solved with more conventional treatments or with behaviors based on promoting health and reproductive habits.
fertilization | Q14890574 |
reproductive techniques | Q65361825 |
medical procedure | Q796194 |
P7870 | Analysis & Policy Observatory term ID | 53311 |
P268 | Bibliothèque nationale de France ID | 11991308j |
P673 | eMedicine ID | 263907 |
P10565 | Encyclopedia of China (Third Edition) ID | 107006 |
P8015 | Encyclopedia on Early Childhood Development ID (English) | assisted-reproductive-technology |
P3219 | Encyclopædia Universalis ID | assistance-medicale-a-la-procreation-procreation-medicalement-assistee |
fivete | ||
P646 | Freebase ID | /m/04zhw8 |
P227 | GND ID | 4125695-5 |
P12385 | Gran Enciclopèdia Catalana ID | fecundacio-artificial |
P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0183354 |
P269 | IdRef ID | 027986489 |
P244 | Library of Congress authority ID | sh88005587 |
P486 | MeSH descriptor ID | D027724 |
P672 | MeSH tree code | E02.875.800 |
E05.820.800 | ||
P6366 | Microsoft Academic ID | 500014431 |
133171274 | ||
2776814571 | ||
2777402159 | ||
2910881241 | ||
P12596 | museum-digital tag ID | 104376 |
P8189 | National Library of Israel J9U ID | 987007532019705171 |
P950 | National Library of Spain ID | XX542622 |
P11902 | NCI Dictionary of Genetics Terms entry | art |
assisted-reproductive-technology | ||
P691 | NL CR AUT ID | ph126918 |
ph183305 | ||
P10283 | OpenAlex ID | C500014431 |
P1051 | PSH ID | 12825 |
P5082 | Store medisinske leksikon ID | assistert_befruktning |
P12800 | Vikidia article ID | fr:Reproduction_du_futur |
P3471 | WikiSkripta article ID | 15822 |
P2347 | YSO ID | 5682 |
P1542 | has effect | procreation | Q1899900 |
P910 | topic's main category | Category:Assisted reproductive technology | Q8271804 |
P1424 | topic's main template | Template:Assisted reproductive technology | Q6689115 |
Q112526462 | Adam H. Balen |
Q93435835 | Adrienne E. Crosier |
Q7508 | Ann A. Kiessling |
Q87964254 | Britta C Van Beers |
Q39381845 | Bryan Woodward |
Q692611 | Carl Wood |
Q57987158 | Catherine Mills |
Q124642587 | Daniela Šplíchalová |
Q104840347 | Denisa Hledíková |
Q88228431 | Elaine Denny |
Q42776941 | Erma Z. Drobnis |
Q5529958 | Geeta Nargund |
Q126325234 | Hassan N. Sallam |
Q121297705 | Helena Bakar |
Q42904475 | Ignacio Palomo Álvarez |
Q112513146 | Kristýna Frühaufová |
Q92627851 | Lukas Landsmann |
Q125166573 | Marek Drábek |
Q124625288 | Martina Moosová |
Q112561587 | Michael G. Chapman |
Q124614838 | Milan Daněk |
Q85588897 | Panagiotis Drakopoulos |
Q7150251 | Paul Devroey |
Q73399658 | Ramadan A Saleh |
Q114655848 | Rhonda Mary Shaw |
Q93137528 | Steven R Lindheim |
Q98230265 | Tamar R Medina-Artom |
Q2571164 | Wilfried Feichtinger |
Q112500798 | William A. Sadler |
Q117962624 | Šárka Čechová |
Q117083364 | assisted reproductive technology in Russia |
Q64605863 | assisted reproductive technology law |
Q111952068 | fertility fraud |
Q16039274 | medical assistance to procreation in France |
Q124168584 | posthumous reproduction |
Q110533693 | Q110533693 |
Q111674629 | Q111674629 |
Q111674731 | Q111674731 |
Q111674790 | Q111674790 |
Q111674807 | Q111674807 |
Q111675083 | Q111675083 |
Q111675236 | Q111675236 |
Q111675237 | Q111675237 |
Q111675238 | Q111675238 |
Q111675470 | Q111675470 |
Q111675521 | Q111675521 |
Q97709577 | Q97709577 |
Q97722708 | Q97722708 |
Q97725939 | Q97725939 |
Q97726748 | Q97726748 |
Q97756101 | Q97756101 |
Q97756109 | Q97756109 |
Q97756110 | Q97756110 |
Q97756133 | Q97756133 |
Q97756966 | Q97756966 |
Q97761827 | Q97761827 |
Q97761923 | Q97761923 |
Q97762017 | Q97762017 |
Q97763559 | Q97763559 |
Q97767875 | Q97767875 |
Q97768617 | Q97768617 |
Q97769289 | Q97769289 |
Q97776298 | Q97776298 |
Q97777465 | Q97777465 |
Q97777496 | Q97777496 |
Q97779469 | Q97779469 |
Q97783052 | Q97783052 |
Q97784394 | Q97784394 |
Q97789098 | Q97789098 |
Q97793680 | Q97793680 |
Q97793757 | Q97793757 |
Q97794071 | Q97794071 |
Q97794104 | Q97794104 |
Q97794107 | Q97794107 |
Q97820992 | Q97820992 |
Q97822129 | Q97822129 |
Q97823359 | Q97823359 |
Q97823676 | Q97823676 |
Q97825762 | Q97825762 |
Q97828334 | Q97828334 |
Q97828498 | Q97828498 |
Q97828648 | Q97828648 |
Q97829396 | Q97829396 |
Q97829660 | Q97829660 |
Q97832248 | Q97832248 |
Q97832286 | Q97832286 |
Q97832518 | Q97832518 |
Q97837467 | Q97837467 |
Q97837713 | Q97837713 |
Q97838335 | Q97838335 |
Q97838562 | Q97838562 |
Q97840257 | Q97840257 |
Q97843551 | Q97843551 |
Q97847725 | Q97847725 |
Q97847885 | Q97847885 |
Q97848027 | Q97848027 |
Q97851700 | Q97851700 |
Q97853643 | Q97853643 |
Q97853650 | Q97853650 |
Q97854680 | Q97854680 |
Q97854702 | Q97854702 |
Q97911049 | Q97911049 |
Q97911057 | Q97911057 |
Q97926800 | Q97926800 |
Q97970428 | Q97970428 |
Q97974728 | Q97974728 |
Q97974771 | Q97974771 |
Q97974909 | Q97974909 |
Q97979822 | Q97979822 |
Q97990860 | Q97990860 |
Q97991518 | Q97991518 |
Q98001642 | Q98001642 |
Q98001712 | Q98001712 |
Q98001722 | Q98001722 |
Q98001805 | Q98001805 |
Q98120457 | Q98120457 |
Q98121636 | Q98121636 |
Q98138462 | Q98138462 |
Q98143018 | Q98143018 |
Q98145539 | Q98145539 |
Q98406875 | Q98406875 |
Q98408135 | Q98408135 |
Q98409587 | Q98409587 |
Q98427903 | Q98427903 |
Q98438310 | Q98438310 |
Q98439515 | Q98439515 |
Q98440690 | Q98440690 |
Q98443038 | Q98443038 |
Q98443155 | Q98443155 |
Q98446001 | Q98446001 |
Q98459506 | Q98459506 |
Q98460313 | Q98460313 |
Q98530960 | Q98530960 |
Q98747903 | Q98747903 |
Q99318819 | Q99318819 |
Q99338676 | Q99338676 |
Q99339855 | Q99339855 |
Q99342763 | Q99342763 |
Q99345056 | Q99345056 |
Q99350384 | Q99350384 |
Q99384757 | Q99384757 |
Q99769305 | Q99769305 |
Q122017472 | Asistovaná reprodukce |
Q122131950 | Guidelines Evropské urologické asociace pro mužskou infertilitu (2020): s aktualizací o hodnoty 6. vydání WHO laboratorního manuálu pro vyšetření a zpracování lidského semene (2021) |
Q122031525 | Jak na IVF |
Q121961089 | Lékařská etika |
Q122134822 | Moje IVF |
Q121998942 | NAPROHELP: úspěšná cesta k dítěti: sborník příspěvků v rámci akreditovaného semináře |
Q122096955 | NAPROHELP: úspěšná cesta k dítěti: sborník příspěvků v rámci akreditovaného semináře |
Q121958336 | Nevědomé příčiny neplodnosti |
Q122005740 | Náš zázračný příběh: ilustrovaná kniha pro děti, které přišly na svět díky asistované reprodukci |
Q122035451 | Our miraculous story: an illustrated book for children who came into the world thanks to assisted reproduction |
Q121954908 | Právní problematika umělé lidské reprodukce |
Q122032577 | Příprava bovinních embryí definovaného pohlaví v systému in vitro |
Q122017539 | Reprodukční medicína: současné možnosti v asistované reprodukci |
Q122009655 | Rodičem kdykoliv a jakkoliv?: průvodce asistovanou reprodukcí a náhradní rodinnou péčí |
Q122076868 | Spermie v kelímku |
Q122011047 | Unsere Zaubergeschichte: illustriertes Buch für Kinder, die mit Hilfe assistierter Reproduktion auf die Welt gekommen sind |
Q108772976 | Künstliche Befruchtung außerhalb des Mutterleibes / Clifford Grobstein. - (8.1979) |
Q37542017 | "Public" perceptions of gamete donation: a research review |
Q64087509 | A Novel Predictive Model to Estimate the Number of Mature Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing Fertilization/Intracytoplasmic Sperm Injection: The ART Calculator |
Q67596712 | A Review of Second- and Third-line Infertility Treatments and Supporting Evidence in Women with Polycystic Ovary Syndrome |
Q64108700 | A cost-effectiveness analysis of preimplantation genetic testing for aneuploidy (PGT-A) for up to three complete assisted reproductive technology cycles in women of advanced maternal age |
Q34875744 | A review of luteinising hormone and human chorionic gonadotropin when used in assisted reproductive technology |
Q35123422 | A short review of ovarian stimulation in assisted reproductive techniques |
Q47115815 | A systematic review and meta-analysis of psychological predictors of successful assisted reproductive technologies |
Q56899716 | ART and pregnancy rates |
Q79230186 | ASRM 2003. Abstracts of the 59th annual meeting of the American Society for Reproductive Medicine. October 11-15, 2003. San Antonio, Texas, USA |
Q51896833 | Aberrant CpG methylation of the imprinting control region KvDMR1 detected in assisted reproductive technology-produced calves and pathogenesis of large offspring syndrome. |
Q85234865 | Abstracts of WARM 2010, the 5th Congress of the World Association of Reproductive Medicine. Moscow, Russia. October 10-13, 2010 |
Q107973117 | An Assessment of Aspirin Plus Prednisone Treatment for Euthyroid Women With Thyroid Autoimmunity |
Q28077711 | Are there optimal numbers of oocytes, spermatozoa and embryos in assisted reproduction? |
Q92218846 | Assisted Reproductive Technology as a Transcutaneous Route for Bacterial Contamination of Ovarian Endometrioma with Coagulase-Negative Staphylococcus: Case Report and Review of the Literature |
Q35549985 | Assisted conception. I--General principles |
Q35766037 | Assisted reproduction treatment and epigenetic inheritance. |
Q27013809 | Assisted reproductive technologies (ARTs): evaluation of evidence to support public policy development |
Q24798560 | Assisted reproductive technologies in rhesus macaques |
Q64070183 | Assisted reproductive technology and the risk of preeclampsia: an updated systematic review and meta-analysis |
Q42814948 | Association of the change in serum estradiol (E2) levels from the day of to the day after human chorionic gonadotropin (hCG) injection and pregnancy outcome following in vitro fertilization-embryo transfer (IVF-ET) in less than average responders |
Q37393945 | Biological versus chronological ovarian age: implications for assisted reproductive technology. |
Q36641191 | Biotechnological approaches to the treatment of aspermatogenic men. |
Q48224524 | Biotechnologies that empower transgender persons to self-actualize as individuals, partners, spouses, and parents are defining new ways to conceive a child: psychological considerations and ethical issues. |
Q36678693 | Cancer and fertility preservation: fertility preservation in breast cancer patients |
Q28143177 | Cell and molecular biological challenges of ICSI: ART before science? |
Q90030051 | Challenges experienced by clients undergoing assisted reproductive technology in Ghana: An exploratory descriptive study |
Q33836615 | Changes in sex ratio from fertilization to birth in assisted-reproductive-treatment cycles. |
Q64115921 | Chromosome screening using culture medium of embryos fertilised in vitro: a pilot clinical study |
Q57003091 | Clinical Value of Preimplantation Genetic Diagnosis |
Q41696561 | Clinical review of 24-35 year olds conceived with and without in vitro fertilization: study protocol. |
Q45544505 | Comparision of reproductive outcome of the women with hypogonadotropic hypogonadism and tubal factor infertility |
Q73337410 | Comparison of child-rearing problems between mothers with multiple children who conceived after infertility treatment and mothers with multiple children who conceived spontaneously |
Q35124852 | Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology |
Q44616172 | Complete down-regulation is not mandatory for good assisted reproductive treatment cycle outcomes |
Q64260491 | Complications and adverse outcomes in pregnancy and childbirth among women who conceived by assisted reproductive technologies: a nationwide birth cohort study of Japan environment and children's study |
Q57154727 | Comprehensive assessment of cryogenic storage risk and quality management concerns: best practice guidelines for ART labs |
Q47117921 | Congenital Malformations in Infants of Mothers Undergoing Assisted Reproductive Technologies: A Systematic Review and Meta-analysis Study. |
Q28079567 | Cost-effectiveness of varicocele surgery in the era of assisted reproductive technology |
Q38451397 | Critical evaluation of human blastocysts for assisted reproduction techniques and embryonic stem cell biotechnology |
Q47924715 | Cryopreserved embryos in the United States and their availability for research |
Q41608598 | Cryotop Vitrification as Compared to Conventional Slow Freezing for Human Embryos at the Cleavage Stage: Survival and Outcomes |
Q971786 | Debate Camp |
Q42563571 | Demands made for inquiry into operations of reproductive health agency |
Q36189804 | Depression and Anxiety Outcomes Associated with Failed Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis |
Q64226779 | Diagnostic Accuracy of Body Mass Index and Fasting Glucose for The Prediction of Gestational Diabetes Mellitus after Assisted Reproductive Technology |
Q42861603 | Difference between perinatal mortality in multiple pregnancies obtained spontaneously versus assisted reproduction |
Q37612210 | Direct-to-consumer advertising of success rates for medically assisted reproduction: a review of national clinic websites |
Q71514092 | Discrimination against men in infertility treatment |
Q108690410 | Discrimination in Baby Making: The Unconstitutional Treatment of Prospective Parents Through Surrogacy |
Q33807486 | Do women offered assisted reproduction technologies have a higher incidence of gynecologic cancer? A systematic review and meta-analysis |
Q64130187 | Effects of patient education on desire for twins and use of elective single embryo transfer procedures during ART treatment: A systematic review |
Q48693491 | Effects of physiotherapeutic TENS in a woman with unexplained infertility |
Q34596821 | Emotional distress in infertile women and failure of assisted reproductive technologies: meta-analysis of prospective psychosocial studies |
Q37788761 | Endometriosis and assisted reproduction techniques |
Q26799183 | Endometriosis-Related Infertility: The Role of the Assisted Reproductive Technologies |
Q92905568 | Epigenetics and Neurological Disorders in ART |
Q85044698 | Establishing New Paradigms while Reexamining the Old Ones |
Q90028605 | Establishing reproductive potential and advances in fertility preservation techniques for XY individuals with differences in sex development |
Q34699942 | External Human Fertilization / Clifford Grobstein. - (6.1979) |
Q79153026 | Extra embryos |
Q43408204 | Factors associated with ovarian hyperstimulation syndrome (OHSS) and its effect on assisted reproductive technology (ART) treatment and outcome |
Q112931913 | Fertility Factors: Infertility, Medicine and the Law in New Zealand, 1950-2004 |
Q64135219 | Fertility treatment use and breastfeeding outcomes |
Q121551529 | Fertilization |
Q28083516 | First do no harm: uterine natural killer (NK) cells in assisted reproduction |
Q64103553 | First-time mothers' experiences of pregnancy and birth following assisted reproductive technology treatment in Taiwan |
Q73353123 | Foreward: genetic exceptionalism |
Q30921490 | Gaps in the evidence for fertility treatment-an analysis of the Cochrane Menstrual Disorders and Subfertility Group database |
Q26851901 | Gasotransmitters in Gametogenesis and Early Development: Holy Trinity for Assisted Reproductive Technology-A Review |
Q44871188 | Gender reassignment and assisted reproduction. Evaluation of multiple aspects |
Q82500172 | Genetic screening in couples experiencing recurrent assisted procreation failure |
Q33629797 | HIV infection of the male genital tract--consequences for sexual transmission and reproduction |
Q108690343 | Hierarchies of Discrimination in Baby Making: A Response to Professor Carroll |
Q24797240 | High quality sperm for nonhuman primate ART: production and assessment |
Q58141213 | How some Indian baby makers are made: Media narratives and assisted conception in India |
Q57824748 | Human Papilloma Virus (HPV) and Fertilization: A Mini Review |
Q86279826 | Human Sperm Epigenetics in Embryonic Development. |
Q112950060 | Human papillomavirus gene expression in the placenta and its prevalence in an assisted reproduction cohort |
Q112956438 | Identification of vesicles, their contents, and how they may contribute to oocyte quality and female fertility |
Q37700933 | Identifying women with indicators of subfertility in a statewide population database: operationalizing the missing link in assisted reproductive technology research |
Q36594302 | Impact of sperm DNA chromatin in the clinic |
Q64931281 | Infertility & assisted reproduction: A historical & modern scientific perspective. |
Q36942377 | Infertility and the provision of infertility medical services in developing countries |
Q34270720 | Infertility care and the introduction of new reproductive technologies in poor resource settings |
Q44959267 | International Federation of Fertility Societies Surveillance 2010: preface |
Q24236483 | Interventions for women with endometrioma prior to assisted reproductive technology |
Q64138075 | Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015 |
Q3454876 | Italian fertility laws referendum, 2005 |
Q58599172 | Just Molly and Me, and Donor Makes Three: Lesbian Motherhood in the Age of Assisted Reproductive Technology |
Q112955316 | Kin-making in the Reproductive Penumbram: Surrogacy in Aotearoa New Zealand |
Q6458274 | LGBT rights opposition |
Q64251866 | LH Levels May Be Used as an Indicator for the Time of Antagonist Administration in GnRH Antagonist Protocols-A Proof-Of-Concept Study |
Q34530622 | Large offspring syndrome and other consequences of ruminant embryo culture in vitro: relevance to blastocyst culture in human ART. |
Q91239845 | Length of stay and cost of birth hospitalization: effects of subfertility and ART |
Q108458978 | Let She Who has the Womb Speak: Regulating the use of Human Oocyte Cryopreservation to the Detriment of Older Women |
Q39825860 | Life After HIV: Examination of HIV Serodiscordant Couples’ Desire to Conceive Through Assisted Reproduction |
Q35686684 | Lifestyle and Outcomes of Assisted Reproductive Techniques: A Narrative Review |
Q43956444 | Longitudinal depressive symptoms and state anxiety among women using assisted reproductive technology |
Q42950977 | Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist–triggered assisted reproductive technique cycles: understanding a new approach |
Q79273326 | Methodologic pitfalls in assessing the efficacy of recombinant follicle-stimulating hormone versus human menopausal gonadotropin in assisted reproduction |
Q26813707 | Methods for assessing the quality of mammalian embryos: How far we are from the gold standard? |
Q28076868 | Microtubule assembly crucial to bovine embryonic development in assisted reproductive technologies |
Q37242919 | Mitochondrial replacement techniques: egg donation, genealogy and eugenics |
Q73395079 | Mode of conception, placental morphology and perinatal outcome of twin gestations |
Q53463156 | Monochorionic triamniotic triplet pregnancies with assisted reproductive technology: Two case reports |
Q112860389 | Negotiating infertility treatment decisions |
Q42214597 | Non-Invasive Approaches to Epigenetic-Based Sperm Selection |
Q64094848 | Novel uterine lavage system for recovery of human embryos fertilized and matured in vivo |
Q42425277 | Our environment and our gametes: what human ARTs can add to the discourse |
Q36628746 | Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis. |
Q83923040 | Ovarian hyperstimulation syndrome: report of six cases |
Q111965662 | Parental Preferences and Procreative Choices: Reproductive Liberty and the Regulation of Preimplantation Genetic Diagnosis |
Q34247407 | Patient selection criteria for blastocyst culture in IVF/ICSI treatment |
Q35069456 | Preconception care and treatment with assisted reproductive technologies |
Q86270664 | Predictors of Pregnancy Rate in Assisted Reproductive Technology According to Actual Guidelines |
Q44600417 | Pregnancy and delivery after traumatic panhypopituitarism |
Q24801034 | Pregnancy initiation in the rhesus macaque: towards functional manipulation of the maternal-fetal interface |
Q50100972 | Premature Birth, low Birth Weight and Birth Defects after assisted reproductive therapies. a 18-year comparative study |
Q53721642 | Prenatal Diagnosis after ART Success: The Role of Early Combined Screening Tests in Counselling Pregnant Patients |
Q85170282 | Problems and intervention strategies of Chinese medicine on assisted reproductive technology |
Q85115925 | Professional Practice Evaluation: How to improve quality management in procreation centers? |
Q44084147 | Providing assisted reproductive care to male haemophiliacs infected with human immunodeficiency virus: preliminary experience |
Q28394143 | Recent advances in bird sperm morphometric analysis and its role in male gamete characterization and reproduction technologies |
Q64264539 | Recent advances in understanding and managing male infertility |
Q56927575 | Recent developments in genetics and medically assisted reproduction: from research to clinical applications |
Q35579762 | Recombinant human follicle-stimulating hormone versus urinary-derived human menopausal gonadotropin for controlled ovarian stimulation: the science and art of assisted reproductive technologies |
Q48693481 | Reproductive tourism and the quest for global gender justice |
Q55296022 | Resources and race: assisted reproduction in Ecuador. |
Q85015837 | Results in assisted reproductive techniques: interpretation and function |
Q64124378 | Risk of Preeclampsia in Pregnancies After Assisted Reproductive Technology and Ovarian Stimulation |
Q28075554 | Risk of adverse pregnancy and perinatal outcomes after high technology infertility treatment: a comprehensive systematic review |
Q43995035 | Sacred conceptions: clinical theodicies, uncertain science, and technologies of procreation in India |
Q28217263 | Safeguarding ART |
Q28067859 | Salpingectomy before assisted reproductive technologies: a systematic literature review |
Q102055846 | Sex differences in infant health following ART-treated, subfertile, and fertile deliveries |
Q73330681 | Sperm DNA fragmentation decreases the pregnancy rate in an assisted reproductive technique |
Q24799231 | Sperm preparation for ART |
Q26783148 | Sperm selection in natural conception: what can we learn from Mother Nature to improve assisted reproduction outcomes? |
Q48829165 | Spontaneous abortion among pregnancies conceived using assisted reproductive technology in the United States*1 |
Q114098220 | Spontaneous and ART-induced large offspring syndrome: similarities and differences in DNA methylome |
Q26740151 | Synergies between assisted reproduction technologies and functional genomics |
Q37576376 | Systematic review of worldwide trends in assisted reproductive technology 2004-2013. |
Q79152538 | The ART of infertility |
Q108274940 | The Art of Giving - Through Volunteerism and Philanthropy: The Ghana Experience |
Q37236952 | The Human Oocyte Preservation Experience (HOPE) a phase IV, prospective, multicenter, observational oocyte cryopreservation registry |
Q30245262 | The Impact of Adenomyosis on Women's Fertility |
Q55451032 | The Indian IVF saga: a contested history. |
Q73353035 | The New Reproductive Technologies: An Overview and Theological Assessment |
Q28066065 | The axoneme: the propulsive engine of spermatozoa and cilia and associated ciliopathies leading to infertility |
Q35569431 | The cryobiology of assisted reproduction |
Q37798880 | The effect of paternal age on assisted reproduction outcome |
Q34052983 | The evolution of legislation in the field of Medically Assisted Reproduction and embryo stem cell research in European union members |
Q28087197 | The paternal genome and the health of the assisted reproductive technology child |
Q37800195 | The public health implications of assisted reproductive technologies |
Q46037018 | The risk of cytogenetic abnormalities in the late first trimester of pregnancies conceived through assisted reproduction |
Q42879751 | The role of food supplementation in the treatment of the infertile couple and for assisted reproduction |
Q37147393 | The role of varicocele repair in the new era of assisted reproductive technology |
Q35538481 | The worldwide impact of iatrogenic pregnancy |
Q39697611 | Therapeutic insemination |
Q47139587 | There is no association between the presence of anti-thyroid antibodies and increased reproductive loss in pregnant women after ART: a systematic review and meta-analysis |
Q39094406 | Third-party reproductive assistance around the Mediterranean: comparing Sunni Egypt, Catholic Italy and multisectarian Lebanon |
Q96437163 | Tunisian Recommendations for resumption of Reproductive Medicine activity in the Covid-19 pandemic |
Q41608737 | Ultrastructural evaluation of human metaphase II oocytes after vitrification: closed versus open devices |
Q45723668 | Understanding the Motivations, Concerns, and Desires of Human Immunodeficiency Virus 1–Serodiscordant Couples Wishing to Have Children Through Assisted Reproduction |
Q64124965 | Using multiple imputation to address the inconsistent distribution of a controlling variable when modeling an infrequent outcome |
Q27023797 | Utility of antioxidants during assisted reproductive techniques: an evidence based review |
Q33848219 | Vitamin D and assisted reproduction technologies: current concepts |
Q108689714 | What About the Children? A Call for Regulation of Assisted Reproductive Technology |
Q28081487 | What contributes to disparities in the preterm birth rate in European countries? |
Q37789744 | What to Do When ICSI Fails |
Q84695459 | Which assisted reproduction technique as a function of sperm morphology? |
Q24632524 | Why do patients discontinue fertility treatment? A systematic review of reasons and predictors of discontinuation in fertility treatment |
Q36620454 | Why we should talk about compliance with assisted reproductive technologies (ART): a systematic review and meta-analysis of ART compliance rates |
Q112904955 | Women’s experience of pregnancy and early motherhood following repeated IVF treatment: a phenomenological study |
Q7311392 | religious response to assisted reproductive technology |
Q73399739 | “Floating denominators”—effect of verification bias on accuracy estimates for preimplantation diagnos |
Q108298372 | Abrogation ou non, la droite hésite |
Q108298253 | Appel à manifester dimanche 21 avril pour le Mariage pour tous |
Q108299608 | Au bout de la nuit, le mariage pour tous |
Q108299465 | Bioéthique La PMA pour toutes validée, avant l’adoption définitive le 29 juin |
Q108299549 | Bioéthique Le Défenseur des droits confirme son soutien à la PMA pour toutes |
Q108299539 | Bioéthique Le gouvernement planche sur la filiation des enfants nés de PMA |
Q108299486 | Bioéthique Le projet de loi arrive au Sénat |
Q108299546 | Bioéthique Le projet de loi en Conseil des ministres en juin |
Q108299482 | Bioéthique. La PMA pour toutes adoptée, des divisions dans la Macronie |
Q108299484 | Bioéthique. La PMA pour toutes fait son retour à l’Assemblée nationale |
Q108299553 | Bioéthique. Le Comité d’éthique a livré sa feuille de route et dit oui à la PMA |
Q108299541 | Bioéthique. Sept ans après, la PMA pour toutes passe enfin par l’Élysée |
Q108299576 | Ce que proposait concrètement la loi sacrifiée |
Q108299550 | Comment réussir l’ouverture de la PMA ? |
Q108299555 | Don de gamètes, cellules reproductrices humaines : qu’est-ce qui justifie l’anonymat ? |
Q108299492 | Elsa Faucillon « La PMA pour toutes doit être assortie d’une égalité effective » |
Q108299609 | En politique aussi, la quantité nuit à la qualité |
Q108299563 | En quoi ouvrir la PMA aux couples de femmes serait-il un problème ? |
Q108299562 | Et la PMA pour toutes, M. Hollande ? |
Q108299574 | Famille, un renoncement lourd de dangers |
Q108299490 | Famille. Elle a fait deux bébés toute seule, et alors ? |
Q108299557 | Faut-il ouvrir la procréation médicale assistée (PMA) à toutes les femmes ? |
Q108298153 | Feu vert pour la PMA, orange pour l’autoconservation des ovocytes |
Q108299537 | François Olivennes « La France va enfin rattraper ses voisins sur la PMA » |
Q108299617 | Françoise Héritier «Rien de ce qui nous paraît naturel n’est naturel» |
Q108299543 | Homosexualité. À la Marche des fiertés, la fête et la lutte restent entremêlées |
Q108299552 | Ils n’ont pas honte !. L’archevêque de Paris en croisade |
Q108299551 | Ils n’ont pas honte !. PMA : le Conseil d’État s’érige en censeur |
Q108299540 | Irène Théry « Les familles issues de dons sont aussi belles, dignes et légitimes que les autres » |
Q108299601 | Jean-Luc Romero « Quand on donne un droit à une partie de la société, tout le monde en bénéficie » |
Q108299545 | LGBTQI+. Discriminations à l’adoption et à la PMA : ça suffit ! |
Q108299565 | La Manif pour tous attise les convoitises |
Q108299564 | La Manif pour tous peine à faire famille |
Q108299603 | La PMA ne doit pas être enterrée (Ian Brossat - PCF) |
Q69364882 | La PMA pour toutes en débat |
Q108299477 | La PMA pour toutes les femmes encore repoussée |
Q108299614 | La droite mobilisée, la gauche confiante |
Q108299566 | La justice incite le gouvernement à aller plus loin sur la PMA |
Q108299568 | La loi Taubira enfin consolidée ? |
Q108298270 | La procréation assistée doit être ouverte aux couples de lesbiennes |
Q108299580 | Le chantier de la loi famille officiellement ouvert |
Q108299582 | Le débat sur la PMA reporté : l’égalité au compte-goutte (Ian Brossat, PCF) |
Q108299575 | Les abandons sont légion |
Q108299584 | Les mêmes droits ! |
Q108299468 | Lesbiennes, comment passer de l’invisibilité à la reconnaissance ? |
Q108299548 | Leçons d’histoire |
Q108299538 | Loi bioéthique. Tardive mise à jour sur la filiation |
Q108299488 | Loi bioéthique. Un baroud d’honneur réac contre la PMA |
Q108299463 | Loi de bioéthique. La PMA pour toutes définitivement adoptée |
Q108299573 | L’exécutif ridiculisé par son recul sur la loi famille |
Q108299544 | Majorité. La PMA, un emblème pour laREM |
Q108299586 | Mariage pour tous : l’Assemblée publie les bans |
Q108299621 | Mariage pour tous : « Un grand front républicain pour l’égalité » |
Q108299612 | Mariage pour tous et GPA : la droite polémique |
Q108299615 | Mariage pour tous : le long périple d’un droit nouveau |
Q108299607 | Marie-George Buffet « Avec du courage, la gauche réussit » |
Q108299611 | Marie-George Buffet « Les combats pour l’égalité enfin reconnus » |
Q108299605 | Mères porteuses : don ou commerce ? table ronde |
Q108299604 | Méres porteuses. Elles ont dit... |
Q108299572 | Nous ne sommes pas du genre à avoir peur et à reculer |
Q108299554 | Ouverture de la PMA à toutes les femmes, une promesse qui attendra 2019 |
Q108299579 | PMA : Le gouvernement ne doit pas céder sur l'égalité (PCF) |
Q108299567 | PMA : notre enfant n'est pas une "fraude" ! |
Q108299480 | PMA pour toutes : comment expliquer le retard français ? DEBAT |
Q108299610 | PMA, la controverse reportée, le débat continue |
Q108299578 | PMA, le gouvernement cède devant les réactionnaires |
Q108299547 | PMA. La République en Marche condamne les propos d’Agnès Thill |
Q108299467 | PMA. La loi bioéthique revient en deuxième lecture à l’Assemblée nationale |
Q108299556 | PMA : une coalition rétrograde des intégristes et des obscurantistes |
Q108299559 | Paris. Un seul mot d'ordre à la Gay Pride 2017 : la PMA pour toutes ! |
Q108299494 | Parlement. La droite réactionnaire en embuscade sur la PMA pour toutes |
Q108299602 | Pendant la campagne, François Hollande s’y était engagé |
Q108299536 | Petit tour d’horizon du projet de loi bioéthique |
Q108298579 | Pour Buffet, la PMA, c’est maintenant |
Q108299620 | Procréation assistée, la gauche divisée |
Q108299473 | Protestations à Paris contre une PMA « au rabais » |
Q108299558 | Schiappa promet la PMA pour toutes en 2018 |
Q108299618 | Tribune : La PMA élargit un droit, la GPA crée de nouvelles dominations |
Q108299475 | Télévision. César et Marceau ou l’enfant malade et le bébé de l’espoir |
Q108299569 | Une discrimination flagrante |
Q108299583 | Une « marche de victoire » |
Q108298200 | Vers un abandon de l’amendement PMA ? |
Q108299542 | Virginie Rio « Un grand pas en avant… et une nouvelle discrimination » |
Q108299616 | « Le mariage, juste une question de droits » |
Q108299570 | « Les enfants nés de la PMA existent, pourquoi les nier ? » |
Q108299585 | « On a la même vie que les hétéros et là, enfin, on aura les mêmes droits » |
Q108299606 | Égalité : deux mamans pour 3 filles |
Q108299560 | Égalité La ministre des Familles confirme une (timide) ouverture sur la PMA |
Q108299471 | Égalité. Une maman + une maman = un enfant |
Q119496195 | bipaternalism | instance of | P31 |
Q6689115 | Template:Assisted reproductive technology | template has topic | P1423 |
Q8271804 | Category:Assisted reproductive technology | category's main topic | P301 |
Q237118 | embryo transfer | part of | P361 |
uri / http://www.wikidata.org/entity/L1345905-S1 | L1345905-S1 | item for this sense | P5137 |
Q334645 | surrogacy | has part(s) | P527 |
Q1899900 | procreation | has cause | P828 |
Q113664490 | endometriosis-related infertility | possible treatment | P924 |
Search more.